biomodal is thrilled to be part of the Scientist Solutions Stanford Expo.
Join us at our table to meet Padhu Srini and discover how biomodal’s groundbreaking multiomic technology illuminates the 6‑base genome and empowers researchers to unravel epigenetic complexity with unprecedented clarity.
Distinguish 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) together with all 4 canonical bases to measure multiple modes of biology from a single low-input DNA sample in a single experiment. The 6-base genome enables multidimensional DNA methylation analysis for biomarker discovery to gain transformative insights into current and future states of disease.
Take first look at biomodal’s newly launched duet mosaic™ family, new workflows for cfDNA and liquid biopsy research that combine genetic, epigenetic, and fragmentomic information from the same molecules, including short, damaged fragments other workflows may miss.